Andrew Blight serves as Executive at ACORDA THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Andrew Blight has executed 454 insider transactions totaling $10.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 6, 2006 involved selling 400 shares valued at $6.4K.
Andrew Blight currently holds 78,594 shares of ACORDA THERAPEUTICS INC (ACOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Blight has been a net seller of ACOR stock. They have purchased $0 and sold $10.1M worth of shares.
Andrew Blight's most recent insider trade was on Nov 6, 2006, when they sold 400 shares at $15.98 per share.
Get notified when new Form 4 filings are submitted
| $16.22 |
| Discretionary |
| Apr 1, 2006 | ACOR | $5.5K | Option Exercise | 3,525 | $1.56 | Discretionary |
| Apr 1, 2006 | ACOR | $2.0K | Option Exercise | 1,282 | $1.56 | Discretionary |